Skip to main content
. 2020 Nov 26;10:564614. doi: 10.3389/fonc.2020.564614

Figure 1.

Figure 1

FMNL1 is overexpressed in ccRCC. (A) Total RNA was extracted from 20 paired ccRCC and corresponding nontumorous tissues (NT) to examine the expression of FMNL1 mRNA by qRT-PCR. (B) The mRNA level in ccRCC patients from TCGA dataset was shown (C). The upregulation of FMNL1 mRNA expression in ccRCC tissues was validated in previous studies of Gumz and Yusenko. (D) The protein expression of FMNL1 was examined by western blot in 20 ccRCC specimens. Representative images were shown. (E) A cohort containing 306 ccRCC patents was recruited to construct TMA. IHC was performed to indicate the FMNL1 expression. FMNL1 expression in tumor and nontumorous tissues, and in ccRCC tissues with or without tumor metastasis was indicated by box and whiskers. (F) Patients were divided into FMNL1high and FMNL1low groups, according to the IHC score of FMNL1 in ccRCC tissues. Kaplan-Meier survival analyses were performed to reveal the prognostic value of FMNL1 in overall and disease-free survivals of ccRCC patients. (G) The prognostic value of FMNL1 in ccRCC was confirmed in TCGA cohort.